Shenzhen, Guangdong, China Dingxin Capital is the famous VC, which was founded in 2014. The venture was found in Asia in China. The main department of described VC is located in the Shenzhen.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Etailor, Koning Among the most successful fund investment fields, there are Health Care, E-Commerce.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Dingxin Capital, startups are often financed by Sansar Capital. The meaningful sponsors for the fund in investment in the same round are Weipinhui, Oriza Seed Capital (Oriza Yuandian), Guangdong Culture Venture Factory.
The top activity for fund was in 2019. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
| Fund Name | Location |
| Anova Investments | Gauteng, NA - South Africa, South Africa |
| Cogentrix Energy | Charlotte, North Carolina, United States |
| Crossbow Ventures | Florida, United States, West Palm Beach |
| Metric Collective | New York, New York, United States |
| Paragon Partners, India | India, Maharashtra, Mumbai |
| Qamcom | Göteborg, Sweden, Vastra Gotaland |
| SUMA Teruel | - |
| Total Access Fund | Manchester, New Hampshire, United States |
| Zhejiang Feihong Jituan Co., Ltd | China, Fuyang, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ruining Bio | $15M | 24 Jan 2024 | Jiading, Shanghai, China | ||
Legendsemi | $15M | 21 Jun 2023 | Haidian, Beijing, China | ||
Sitrus Technology | 16 May 2023 | Shanghai, Shanghai, China | |||
Ai Ma Biology | 15 May 2023 | Shenzhen, Guangdong, China | |||
Semitech | $77M | 05 May 2023 | Minhang, Shanghai, China | ||
Vivest | 21 Nov 2022 | Suzhou, Jiangsu, China | |||
DHC Medical | 27 Jun 2022 | Shenzhen, Guangdong, China | |||
Weilai Meijia | 09 Jun 2022 | Hangzhou, Zhejiang, China | |||
Resnics | 25 Aug 2021 | Shanghai, Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ruining Bio | $15M | 24 Jan 2024 | Jiading, Shanghai, China | ||
Legendsemi | $15M | 21 Jun 2023 | Haidian, Beijing, China | ||
Sitrus Technology | 16 May 2023 | Shanghai, Shanghai, China | |||
Ai Ma Biology | 15 May 2023 | Shenzhen, Guangdong, China | |||
Semitech | $77M | 05 May 2023 | Minhang, Shanghai, China | ||
Vivest | 21 Nov 2022 | Suzhou, Jiangsu, China | |||
DHC Medical | 27 Jun 2022 | Shenzhen, Guangdong, China | |||
Weilai Meijia | 09 Jun 2022 | Hangzhou, Zhejiang, China | |||
Resnics | 25 Aug 2021 | Shanghai, Shanghai, China |
